Sage Therapeutics Announces Resignation Of Kimi Iguchi From Her Position As CFO And Treasurer Of The Co And From Any And All Other Positions She Holds As An Officer Or Employee Of The Company Or An Officer, Employee Or Director Of Any Of Its Subsidiaries
Portfolio Pulse from Benzinga Newsdesk
Sage Therapeutics announced the resignation of Kimi Iguchi as CFO and Treasurer, effective October 31, 2024, as part of a company reorganization. The separation agreement includes a release of claims and non-solicitation, non-disclosure, and non-disparagement obligations.
November 01, 2024 | 8:44 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Sage Therapeutics' CFO Kimi Iguchi has resigned as part of a company reorganization. This could indicate internal restructuring and potential changes in financial strategy.
The resignation of a CFO can lead to uncertainty regarding the company's financial strategy and stability. This is part of a broader reorganization, which may affect investor confidence in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100